Biomarker Discovery Programs

About Orion Genomics

Orion Genomics is a private, established biotech firm with a dual focus on human health diagnostics and agricultural bioscience. The company's core strength lies in its epigenetic and genomic biomarker discovery platform, supported by over 100 patents and a CLIA-certified clinical laboratory for assay development. It commercializes its technology through partnerships, notably with the Malaysian Palm Oil Board via its subsidiary Orion Biosains for oil palm improvement, while also pursuing internal diagnostic pipelines. Orion appears to be in an early-revenue stage, generating income from services and partnerships rather than proprietary commercial products.